Hedge funds don't get the respect they used to get. Nowadays investors prefer passive funds over actively managed funds. One thing they don't realize is that 100% of the passive funds didn't see the c
Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) have been assigned a consensus rating of “Buy” from the six ratings firms that are covering the company, Marketbeat.com reports. Two research analys
Mesa Laboratories (NASDAQ:MLAB) was downgraded by investment analysts at ValuEngine from a “buy” rating to a “hold” rating in a note issued to investors on Friday, ValuEngine reports. Several
Average weekly trading volume of approximately 1,741,154 shares
Assenagon Asset Management S.A. purchased a new stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commissi
Mesa Laboratories (NASDAQ:MLAB) has had a rough three months with its share price down 20%. We, however decided to...
While Mesa Laboratories, Inc. (NASDAQ:MLAB) shareholders are probably generally happy, the stock hasn't had...
Equities research analysts expect that Mesa Laboratories, Inc. (NASDAQ:MLAB) will announce earnings of $2.03 per share for the current fiscal quarter, Zacks reports. Two analysts have provided estimat
Apr 20, 2020 (The Expresswire) -- The report outlines the competitive framework of the “Biological Indicators Market” industry detailing the SWOT analysis...
Wall Street analysts expect Mesa Laboratories, Inc. (NASDAQ:MLAB) to announce $34.50 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estima
Bank of America Corp DE grew its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 1.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (S
Goldman Sachs Group Inc. lowered its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 79.6% during the fourth quarter, according to the company in its most recent filing with the SEC. The institution
AQR Capital Management LLC lessened its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) by 16.5% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Com
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE